维普期刊资源整合服务平台（V6.5）

69篇 您的检索式：作者名="LASHO T"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	JAK2 617F mutation in essential thrombocy thaemia: clincal associations and long-term prognostic relevance 显示文摘	WOLANSKYI A P LASHO T L SCHWAGER S M	2005	Br J Haematol2005，131，2：	1
2	MPL515 mutations in myeloproliferative and other myeloid disorders:a study of 1182patients显示文摘	Pardanani AD Levine RL Lasho T		0，，10：	1
3	MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients显示文摘	Pardanani AD Levine RL Lasho T	2006	Blood2006，108，10：	1
4	Validation of two clinically useful assays for evaluation of JAK2V617F mutation in chronic myeloproliferative disorders显示文摘	McClure R Mai M Lasho T	2006	Leukemia2006，20，1：	1
5	The JAK2 tyrosine kinase mutation in myelofibrosis with myeloid metaplasia; lineage specificity and clinical correlates 显示文摘	TEFFERI A LASHO T L SCHWAGER S M	2005	Br J Haematol2005，131，3：	1
6	The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both 'atypical' myeloproliferative disorders and myelodysplastic syndromes显示文摘	STEENSMA D P DEWALD G W LASHO T L	2005	Blood2005，106，：	1
7	Clinical correlates of JAK2V617Fallele burden in es-sential thrombocythemia显示文摘	KITTUR J KNUDSON R A LASHO T L	2007	Cancer2007，109，：	1
8	MPI-515 mutations in myelo- proliferative and other myeloid disorders :a study of 1182 patients显示文摘	Pardanani AD Levine RL Lasho T	2006	Blood2006，108，10：	1
9	Validation of two clinically useful assays for evaluation of JAK2 V617F mutation in chronic myelop roliferarive disorders显示文摘	McClure R.MaiM Lasho T		0，，：	1
10	SF3B1 mutations in primary myelofibrosis: Clinical, histopath- ology and genetic correlates among 155 patients显示文摘	Lasho T L Finke C M Hanson C A	2012	Leukemia2012，26，5：	1
11	Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia:a Mayo Clinic French Consortium Study显示文摘	Wassie E A Itzykson R Lasho T L	2014	American journal of hematology2014，89，12：	1
12	MPL515 mutations in myeloproliferative and other myeloid disorders:a study of 1182 patients显示文摘	Pardanani A D Levine R L Lasho T		0，，：	1
13	The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both 'atypical'myeloproliferative disorders and myelodysplastic syndromes显示文摘	Steensma D P Dewald G W Lasho T L	2005	Blood2005，106，4：	1
14	Concomitantneutrophil JAK2 mutation screening and PRV-1 expres-sionanalysis in myeloproliferative disorders and secondarypolycy-thaemia显示文摘	TEFFERI A SIRHAN S LASHO T L	2005	Br J Haematol2005，131，2：	1
15	MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1 182 patients 显示文摘	Pardanani AD Levine RL Lasho T	2006	Blood2006，108，10：	1
16	MPL515 mutations in myeloproliferative and other myeloid disorders:a study of 1182 patients显示文摘	Pardanani AD Levine RL Lasho T	2006	Blood2006，108，10：	1
17	Validation of two clinically useful assays for evaluation of JAK2 V617F mutation in chronic myeloproliferative disorders显示文摘	Mcclure R Mai M Lasho T	2006	Leukemia2006，20，1：	1
18	MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1 182 patients 显示文摘	Pardanani AD Levine RL Lasho T	2006	Blood2006，108，10：	1
19	MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients 显示文摘	PARDANANI A D LEVINE R L LASHO T	2006	Blood2006，108，10：	1
20	SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survival 显示文摘	Lasho TL Jimma T Finke CM	2012	Blood2012，120，20：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示